Skip Ribbon Commands
Skip to main content

Study Lists

Sharing knowledge. Sharing Hope.
Skip Navigation LinksHome   /   Studies   /   Clinical Outcomes Research   /   Study Lists   /   Observational Study
  • Print
  • Share


Recently Completed Studies

Study # MM17-02
Study Status: Published
Working Committee: Plasma Cell Disorders


Cornell RF, Fraser R, Costa L, Goodman S, Estrada-Merly N, Lee C, Hildebrandt G, Gergis U, Farhadfar N, Freytes CO, Kamble RT, Krem M, Kyle RA, Lazarus HM, Marks DI, Meehan K, Patel SS, Ramanathan M, Olsson RF, Wagner JL, Kumar S, Qazilbash MH, Shah N, Hari P, D'Souza A. Bortezomib-based induction is associated with superior outcomes in light chain amyloidosis patients treated with autologous hematopoietic cell transplantation regardless of plasma cell burden. Transplantation and Cellular Therapy. 2021 Mar 1; 27(3):264.e1-264.e7. doi:10.1016/j.jtct.2020.11.018. Epub 2020 Dec 21. PMCID:PMC8010222.


2020, ASCO

PMID: 33781533

Working Committee Contact

Omar Dávila (Unknown)
Last Updated: 10/29/2010 4:55 PM